SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PSDV - pSivida Limited
PSDV 1.220+14.0%Mar 29 4:00 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: John McCarthy9/27/2014 2:35:58 AM
   of 421
 
Great win for the patients

I am retina specialist and more than half of my patients are DM, This is GREAT WIN for the patients. As Lucentis, Avastin and Eyelea all are Anti -VEGF, and IMHO does not work that well However Ozurdex which is also a sterioid implant like iluvien which works great(much better than anti-VEGF) , but also only work for 6 month. So , Iluvien will be a great addition to our armamentarium. My nurse already have compiled a list of patient that failed other therapy and will be great candidate Less

finance.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext